Autologous Is Superior to Allogeneic Hematopoietic Cell Transplantation for Acute Promyelocytic Leukemia in Second Complete Remission Jennifer L. Holter Chakrabarty, Morel Rubinger, Jennifer Le-Rademacher, Hai-Lin Wang, Andrew Grigg, George B. Selby, Jeffrey Szer, Jacob M. Rowe, Daniel J. Weisdorf, Martin S. Tallman Biology of Blood and Marrow Transplantation Volume 20, Issue 7, Pages 1021-1025 (July 2014) DOI: 10.1016/j.bbmt.2014.03.025 Copyright © 2014 American Society for Blood and Marrow Transplantation Terms and Conditions
Figure 1 Overall survival in patients undergoing allogeneic and autologous transplantation with APL in CR2. Biology of Blood and Marrow Transplantation 2014 20, 1021-1025DOI: (10.1016/j.bbmt.2014.03.025) Copyright © 2014 American Society for Blood and Marrow Transplantation Terms and Conditions
Figure 2 Disease-free survival in patients undergoing allogeneic and autologous transplantation for APL in CR2. Biology of Blood and Marrow Transplantation 2014 20, 1021-1025DOI: (10.1016/j.bbmt.2014.03.025) Copyright © 2014 American Society for Blood and Marrow Transplantation Terms and Conditions
Figure 3 Treatment-related mortality in patients undergoing allogeneic and autologous transplantation for APL in CR2. Biology of Blood and Marrow Transplantation 2014 20, 1021-1025DOI: (10.1016/j.bbmt.2014.03.025) Copyright © 2014 American Society for Blood and Marrow Transplantation Terms and Conditions